TrialFrontiers in immunology2025

Preventive hyperbaric oxygen therapy improves acute graft-versus-host disease by activating the Nrf2/HO-1 pathway.

Chao Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.